Company Spotlight

Aphena Pharma Solutions

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Stason Pharmaceuticals, Inc.





Company Headquarters

11 Morgan
Irvine, CA 92618
United States

Contract Service Directory

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • Aseptic Processing | cGMP Manufacture | Facilities | Fill/Finish | Formulation Development | Industry News | Lyophilization
      Patheon to Invest $45M to Expand Capabilities

      Patheon to Invest $45M to Expand Capabilities

      Will invest in commercial and development spray drying and flexible manufacturing solutions
      06.29.17

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection
      06.07.17


    • Breaking News | cGMP Manufacture | CRO News | Drug Development | Drug Discovery | Industry News
      AMRI Bought for $922M

      AMRI Bought for $922M

      Purchased by private equity firms The Carlyle Group and GTCR
      06.07.17

    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17


    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17

    • Promotions & Moves

      Akebia Therapeutics Names CMO

      Jain to lead clinical development of the company’s HIF pipeline
      05.25.17

    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17


    • Analytical Services | Drug Development | Fill/Finish | Industry News | Lyophilization
      Alcami Invests $5M to Expand SC Ops

      Alcami Invests $5M to Expand SC Ops

      Will continue to expand its filling and freeze-drying capabilities
      05.04.17

    • Porton USA Acquires J-STAR Research for $26M

      Expands its research and development capabilities
      05.01.17

    • Bio News | Breaking News | Clinical Trials | Drug Development | Industry News
      Espero Pharma and Armetheon Merge

      Espero Pharma and Armetheon Merge

      Creates a premier cardiovascular focused biopharmaceutical company
      04.24.17


    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17

    • Breaking News | Industry News | Lyophilization

      Permira Funds Acquires LSNE

      Matt Halvorsen will remain as LSNE’s chief executive
      03.27.17

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully
      03.06.17

    • APIs | Excipients
      Who Will Win in Pharmaceutical Fine Chemicals?

      Who Will Win in Pharmaceutical Fine Chemicals?

      Western pharmaceutical fine chemicals suppliers must prepare for an uncertain future
      Dr. Enrico T. Polastro, Vice President, Arthur D. Little 01.26.17

    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17

    • Aseptic Processing | Bio News | Bioanalytical Services | Breaking News | Clinical Trial Materials | Industry News

      Amatsigroup Acquires Disposable-Lab

      Enhances capabilities in development services for injectable drug products
      01.20.17